Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PRME Prime Medicine, Inc.

盘前交易 12-18 07:16:57 EST

3.74

-0.14

-3.61%

盘前3.70

-0.04-1.07%

07:00 EST

最高4.12	最低3.72	成交量231.53万
今开3.94	昨收3.88	日振幅10.31%
总市值6.75亿	流通市值3.73亿	总股本1.81亿
成交额895.94万	换手率2.32%	流通股本9,980万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PRME","market":"US","secType":"STK","nameCN":"Prime Medicine, Inc.","latestPrice":3.74,"timestamp":1766005200000,"preClose":3.88,"halted":0,"volume":2315270,"hourTrading":{"tag":"盘前","latestPrice":3.7,"preClose":3.74,"latestTime":"07:00 EST","volume":2,"amount":7.24,"timestamp":1766059210590},"delay":0,"floatShares":99798700,"shares":180510658,"eps":-1.438701,"marketStatus":"盘前交易","change":-0.14,"latestTime":"12-18 07:16:57 EST","open":3.94,"high":4.12,"low":3.72,"amount":8959365.58995,"amplitude":0.103093,"askPrice":3.95,"askSize":23,"bidPrice":3.54,"bidSize":111,"shortable":3,"etf":0,"ttmEps":-1.438701,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1766068200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1666238400000,"exchange":"NASDAQ","adjPreClose":3.74,"preHourTrading":{"tag":"盘前","latestPrice":3.7,"preClose":3.74,"latestTime":"07:00 EST","volume":2,"amount":7.24,"timestamp":1766059210590},"postHourTrading":{"tag":"盘后","latestPrice":3.75,"preClose":3.74,"latestTime":"19:54 EST","volume":18868,"amount":70582.2121,"timestamp":1766019298767},"volumeRatio":0.8276412672834564,"impliedVol":1.7012,"impliedVolPercentile":0.8313},"requestUrl":"/m/hq/s/PRME/tweets","defaultTab":"tweets","newsList":[{"id":"1161194605","title":"Prime Medicine宣布《新英格兰医学杂志》发表Pm359慢性肉芽肿病临床数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1161194605","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1161194605?lang=zh_cn&edition=full","pubTime":"2025-12-07 21:05","pubTimestamp":1765112711,"startTime":"0","endTime":"0","summary":"Prime Medicine宣布《新英格兰医学杂志》发表Pm359慢性肉芽肿病临床数据","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2588749057","title":"Prime Medicine, Inc.盘中异动 临近午盘股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588749057","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588749057?lang=zh_cn&edition=full","pubTime":"2025-12-03 00:49","pubTimestamp":1764694167,"startTime":"0","endTime":"0","summary":"北京时间2025年12月03日00时49分，Prime Medicine, Inc.股票出现异动，股价急速跳水5.00%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.05%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203004927a4c87c49&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251203004927a4c87c49&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"1121243328","title":"Prime Medicine：销售协议招股说明书涵盖不时发行、销售最多2亿美元普通股的事项","url":"https://stock-news.laohu8.com/highlight/detail?id=1121243328","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121243328?lang=zh_cn&edition=full","pubTime":"2025-11-07 21:08","pubTimestamp":1762520898,"startTime":"0","endTime":"0","summary":"Prime Medicine：销售协议招股说明书涵盖不时发行、销售最多2亿美元普通股的事项","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2580246445","title":"Prime Medicine, Inc.盘中异动 快速下挫5.06%报4.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2580246445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2580246445?lang=zh_cn&edition=full","pubTime":"2025-11-03 23:04","pubTimestamp":1762182296,"startTime":"0","endTime":"0","summary":"北京时间2025年11月03日23时04分，Prime Medicine, Inc.股票出现波动，股价大幅下挫5.06%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.74%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230456a48573d3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251103230456a48573d3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"1126222337","title":"新闻稿：Prime Medicine任命Matthew Hawryluk博士为首席商务官","url":"https://stock-news.laohu8.com/highlight/detail?id=1126222337","media":"投资观察","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126222337?lang=zh_cn&edition=full","pubTime":"2025-11-03 21:03","pubTimestamp":1762175015,"startTime":"0","endTime":"0","summary":"马萨诸塞州剑桥，2025年11月3日-- Prime Medicine, Inc.是一家致力于提供新一类差异化的一次性治愈性基因疗法的生物技术公司，今天宣布任命Matthew Hawryluk博士为首席商务官。“我们非常高兴欢迎Matt加入我们的领导团队，” Prime Medicine的首席执行官Allan Reine博士表示。“在这样一个令人激动和关键的时刻加入Prime Medicine，我深感荣幸，”Prime Medicine的首席商务官Matthew Hawryluk博士表示。Prime Medicine明确否认任何基于适用法律的义务去更新任何前瞻性声明。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2579151000","title":"Prime Medicine, Inc.盘中异动 早盘大幅下跌5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579151000","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579151000?lang=zh_cn&edition=full","pubTime":"2025-10-29 21:38","pubTimestamp":1761745093,"startTime":"0","endTime":"0","summary":"北京时间2025年10月29日21时38分，Prime Medicine, Inc.股票出现波动，股价快速下挫5.19%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.54%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213813a6d4fa2b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251029213813a6d4fa2b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2575794853","title":"Prime Medicine, Inc.盘中异动 快速拉升5.18%报6.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2575794853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2575794853?lang=zh_cn&edition=full","pubTime":"2025-10-15 21:43","pubTimestamp":1760535803,"startTime":"0","endTime":"0","summary":"北京时间2025年10月15日21时43分，Prime Medicine, Inc.股票出现异动，股价大幅拉升5.18%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.01%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015214324a4618485&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251015214324a4618485&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2572306891","title":"Prime Medicine, Inc.盘中异动 急速拉升5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572306891","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572306891?lang=zh_cn&edition=full","pubTime":"2025-10-01 03:43","pubTimestamp":1759261422,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日03时43分，Prime Medicine, Inc.股票出现异动，股价快速上涨5.08%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.05%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001034342a44f145d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001034342a44f145d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2558614796","title":"Prime Medicine, Inc.盘中异动 大幅下跌5.02%报3.60美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2558614796","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558614796?lang=zh_cn&edition=full","pubTime":"2025-08-11 23:53","pubTimestamp":1754927616,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日23时53分，Prime Medicine, Inc.股票出现波动，股价快速下跌5.02%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123533694dcf522&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025081123533694dcf522&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2555163836","title":"Prime Medicine, Inc.盘中异动 股价大跌7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2555163836","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555163836?lang=zh_cn&edition=full","pubTime":"2025-07-31 21:31","pubTimestamp":1753968703,"startTime":"0","endTime":"0","summary":"北京时间2025年07月31日21时31分，Prime Medicine, Inc.股票出现波动，股价快速下挫7.02%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.33%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213143a6cbc9f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250731213143a6cbc9f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2518782227","title":"Prime Medicine, Inc.盘中异动 早盘股价大跌5.00%报2.28美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2518782227","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518782227?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:35","pubTimestamp":1741613718,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时35分，Prime Medicine, Inc.股票出现波动，股价大幅下挫5.00%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.07%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021351998a29db8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021351998a29db8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2518996447","title":"Prime Medicine, Inc.2024财年实现净利润-1.96亿美元，同比增加1.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518996447","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518996447?lang=zh_cn&edition=full","pubTime":"2025-03-09 00:00","pubTimestamp":1741449656,"startTime":"0","endTime":"0","summary":"3月9日，Prime Medicine, Inc.公布财报，公告显示公司2024财年净利润为-1.96亿美元，同比增加1.01%；其中营业收入为2.98百万美元，每股基本收益为-1.65美元。从资产负债表来看，Prime Medicine, Inc.总负债3.37亿美元，其中短期债务3.61百万美元，资产负债比为1.46，流动比率为0.06。机构评级：截至2025年3月9日，当前有10家机构对Prime Medicine, Inc.目标价做出预测，其中目标均价为12.90美元，其中最低目标价为6.00美元，最高目标价为19.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000212abef97d9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250309000212abef97d9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME"],"gpt_icon":0},{"id":"2517334924","title":"Prime Medicine, Inc.盘中异动 临近收盘股价大涨5.12%报2.32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517334924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517334924?lang=zh_cn&edition=full","pubTime":"2025-03-06 04:55","pubTimestamp":1741208119,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日04时55分，Prime Medicine, Inc.股票出现异动，股价急速上涨5.12%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为1.97%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045519a261319d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306045519a261319d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2516672350","title":"Citizens Capital Markets：重申Prime Medicine(PRME.US)评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2516672350","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516672350?lang=zh_cn&edition=full","pubTime":"2025-03-04 22:22","pubTimestamp":1741098129,"startTime":"0","endTime":"0","summary":"Citizens Capital Markets：重申Prime Medicine(PRME.US)评级，由优于大市调整至优于大市评级, 目标价由10.00美元调整至10.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/04222248521887.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["PRME"],"gpt_icon":0},{"id":"2516653246","title":"Prime Medicine, Inc.盘中异动 股价大跌5.06%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516653246","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516653246?lang=zh_cn&edition=full","pubTime":"2025-03-04 00:21","pubTimestamp":1741018880,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日00时21分，Prime Medicine, Inc.股票出现异动，股价大幅下挫5.06%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.41%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002120989a2a8a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304002120989a2a8a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2516379709","title":"Prime Medicine, Inc.盘中异动 早盘股价大涨5.37%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516379709","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516379709?lang=zh_cn&edition=full","pubTime":"2025-03-01 00:06","pubTimestamp":1740758766,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日00时06分，Prime Medicine, Inc.股票出现异动，股价快速拉升5.37%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000606abe100e0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301000606abe100e0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"1146217215","title":"Prime Medicine 2024财年GAAP每股收益$(1.65)优于预期$(1.66)，销售额$2.983M超出预期$929.100K","url":"https://stock-news.laohu8.com/highlight/detail?id=1146217215","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1146217215?lang=zh_cn&edition=full","pubTime":"2025-02-28 21:06","pubTimestamp":1740747970,"startTime":"0","endTime":"0","summary":"Prime Medicine 2024财年GAAP每股收益$(1.65)，优于预期$(1.66)，销售额$2.983M，超出预期$929.100K。以上内容来自Benzinga Earnings专栏，原文如下：Prime Medicine FY 2024 GAAP EPS $(1.65) Beats $(1.66) Estimate, Sales $2.983M Beats $929.100K Estimate","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Prime Medicine 2024财年GAAP每股收益$(1.65)优于预期$(1.66)，销售额$2.983M超出预期$929.100K","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRME"],"gpt_icon":0},{"id":"2514386789","title":"Prime Medicine, Inc.盘中异动 早盘急速拉升5.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386789","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386789?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:47","pubTimestamp":1740667672,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时47分，Prime Medicine, Inc.股票出现波动，股价急速上涨5.48%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.80%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224752abdf72d5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250227224752abdf72d5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","PRME"],"gpt_icon":0},{"id":"2514622138","title":"Prime Medicine, Inc.盘中异动 临近收盘股价大跌5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514622138","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514622138?lang=zh_cn&edition=full","pubTime":"2025-02-27 04:42","pubTimestamp":1740602539,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日04时42分，Prime Medicine, Inc.股票出现异动，股价快速跳水5.28%。Prime Medicine, Inc.股票所在的生物技术行业中，整体跌幅为0.72%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022704421996319069&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022704421996319069&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0},{"id":"2514016658","title":"Prime Medicine, Inc.盘中异动 股价大跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514016658","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514016658?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:47","pubTimestamp":1740498439,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时47分，Prime Medicine, Inc.股票出现波动，股价大幅跳水5.14%。Prime Medicine, Inc.股票所在的生物技术行业中，整体涨幅为0.79%。Prime Medicine, Inc.公司简介：Prime Medicine Inc 是一家生物技术公司，致力于通过部署基因编辑技术 Prime Editing 提供基因疗法来治疗疾病。Prime Editing技术是一种可以通过搜索和替换来恢复基因组中正常遗传功能，可以治疗具有高度未满足医疗需求的广泛疾病和高效广泛的基因编辑技术的下一代技术。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523471998925d46&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022523471998925d46&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PRME","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.primemedicine.com","stockEarnings":[{"period":"1week","weight":-0.1363},{"period":"1month","weight":-0.0209},{"period":"3month","weight":-0.2695},{"period":"6month","weight":0.8068},{"period":"1year","weight":0.2852},{"period":"ytd","weight":0.2808}],"compareEarnings":[{"period":"1week","weight":-0.0235},{"period":"1month","weight":0.0086},{"period":"3month","weight":0.0138},{"period":"6month","weight":0.1298},{"period":"1year","weight":0.1111},{"period":"ytd","weight":0.1456}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Prime Medicine, Inc.于2019年9月在特拉华州注册成立。该公司是一家生物技术公司，致力于提供一类新的差异化一次性治疗基因疗法— Prime Editors，通过部署Prime Editing技术来解决最广泛的疾病谱。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.126071},{"month":2,"riseRate":0.333333,"avgChangeRate":0.064547},{"month":3,"riseRate":0,"avgChangeRate":-0.216854},{"month":4,"riseRate":0.333333,"avgChangeRate":-0.102761},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.001492},{"month":6,"riseRate":0.666667,"avgChangeRate":0.318071},{"month":7,"riseRate":1,"avgChangeRate":0.211426},{"month":8,"riseRate":0,"avgChangeRate":-0.164067},{"month":9,"riseRate":0.333333,"avgChangeRate":0.111542},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.141809},{"month":11,"riseRate":0.25,"avgChangeRate":-0.086687},{"month":12,"riseRate":0.5,"avgChangeRate":0.041961}],"exchange":"NASDAQ","name":"Prime Medicine, Inc.","nameEN":"Prime Medicine, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Prime Medicine, Inc.(PRME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Prime Medicine, Inc.,PRME,Prime Medicine, Inc.股票,Prime Medicine, Inc.股票老虎,Prime Medicine, Inc.股票老虎国际,Prime Medicine, Inc.行情,Prime Medicine, Inc.股票行情,Prime Medicine, Inc.股价,Prime Medicine, Inc.股市,Prime Medicine, Inc.股票价格,Prime Medicine, Inc.股票交易,Prime Medicine, Inc.股票购买,Prime Medicine, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Prime Medicine, Inc.(PRME)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Prime Medicine, Inc.(PRME)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}